Skip to content
Scailyte
  • 5th-Year Anniversary Symposium
  • ScaiVision
  • Services
    • Cell & Gene Therapy
    • Immunology & Oncology
  • Discovery Pipeline
  • Publications
  • News
  • About us
×
  • 5th-Year Anniversary Symposium
  • ScaiVision
  • Services
    • Cell & Gene Therapy
    • Immunology & Oncology
  • Discovery Pipeline
  • Publications
  • News
  • About us
Get in touch
Scailyte
  • 5th-year Anniversary Symposium
  • ScaiVision
  • Services
    • Cell & Gene Therapy
    • Immunology & Oncology
  • Discovery Pipeline
  • Publications
  • News
  • About us
×
  • 5th-year Anniversary Symposium
  • ScaiVision
  • Services
    • Cell & Gene Therapy
    • Immunology & Oncology
  • Discovery Pipeline
  • Publications
  • News
  • About us
Get in touch
Scailyte
  • 5th-year Anniversary Symposium
  • ScaiVision
  • Services
    • Cell & Gene Therapy
    • Immunology & Oncology
  • Discovery Pipeline
  • Publications
  • News
  • About us
×
  • 5th-year Anniversary Symposium
  • ScaiVision
  • Services
    • Cell & Gene Therapy
    • Immunology & Oncology
  • Discovery Pipeline
  • Publications
  • News
  • About us
Scailyte
  • 5th-Year Anniversary Symposium
  • ScaiVision
  • Services
    • Cell & Gene Therapy
    • Immunology & Oncology
  • Discovery Pipeline
  • Publications
  • News
  • About us
×
  • 5th-Year Anniversary Symposium
  • ScaiVision
  • Services
    • Cell & Gene Therapy
    • Immunology & Oncology
  • Discovery Pipeline
  • Publications
  • News
  • About us
Get in touch

Scailyte Closes Financing Round and Onboards Top Biotech Leaders

Scailyte closes Series A financing round and onboards top biotech leaders to fuel our growth in 2022​

Scailyte has successfully finished the first closing of their series A. Two new investors joined the round, and most of the existing shareholders engaged with follow-on investments. The second closing is planned for the first half of 2022 and Scailyte is currently in discussions with a number of additional investors.

Continue reading
Scailyte

Contact Information:

Scailyte AG
Lichtstrasse 35
4056 Basel
Switzerland

  • LinkedInCreated with Sketch.
  • D3255223-CCD2-41A0-AFD7-7F9CA3058D9C


USA Contact Information:
Scailyte AG
c/o swissnex Boston
420 Broadway,
Cambridge, MA 02138,
USA

  • Careers
  • Contact us
  • Home
  • Publications
  • News
  • About us
  • ScaiVision
  • Cell & Gene Therapy
  • Immunology & Oncology
  • Discovery Pipeline
Scailyte
Contact Information:

Scailyte AG
WSJ-500.1.101
Lichtstrasse 35
4056 Basel
Switzerland

  • LinkedInCreated with Sketch.
  • D3255223-CCD2-41A0-AFD7-7F9CA3058D9C
  • Clinical IVD Pipeline
  • ScaiVision
  • Partnering
  • Home
  • About
  • News
  • Careers
  • Contact us

Scailyte 2021 © All rights reserved. Scailyte, ScaiVision and the Scailyte logo are registered trademarks.

Terms & Conditions